Join us for this dynamic, CME-certified symposium! Led by Celestia S. Higano, MD, FACP, the expert panel will review the evolving role of PARP inhibitors in prostate cancer, including an overview of DNA repair deficiencies in prostate cancer, guidance on genetic testing, an update on the latest clinical data on PARP inhibitors for the treatment of prostate cancer and future directions, and case discussions of where PARP inhibitors fit into the standard of care setting.
Not an official event of the 2019 Genitourinary Cancers Symposium. Not sponsored, endorsed, or accredited by ASCO or the Conquer Cancer Foundation.
2 upcoming events, beginning 02/14/2019More Information